Protagonist Therapeutics News - PTGX

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Protagonist Therapeutics Inc PTGX NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.09 1.21% 7.52 7.70 7.38 7.46 7.43 23:59:39
more quote information »

Recent News

Date Time Source Heading
1/07/202007:00PRNUSProtagonist Therapeutics Achieves Milestone in Janssen..
1/06/202007:00PRNUSProtagonist Therapeutics Initiates Phase 2 Study of Novel..
12/16/201911:07EDGARStatement of Ownership (sc 13g)
12/03/201918:46EDGARStatement of Changes in Beneficial Ownership (4)
12/03/201918:33EDGARStatement of Changes in Beneficial Ownership (4)
12/03/201918:12EDGARStatement of Changes in Beneficial Ownership (4)
12/03/201918:11EDGARStatement of Changes in Beneficial Ownership (4)
12/03/201907:51EDGARCurrent Report Filing (8-k)
12/03/201907:00PRNUSProtagonist Therapeutics Announces Preliminary Phase 2..
11/27/201917:20EDGARCurrent Report Filing (8-k)
11/27/201917:07EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/27/201914:59EDGARStatement of Changes in Beneficial Ownership (4)
11/25/201906:05EDGARNotice of Effectiveness (effect)
11/13/201907:00PRNUSProtagonist Therapeutics to Present at Two Upcoming..
11/06/201917:13EDGARQuarterly Report (10-q)
11/06/201916:35EDGARCurrent Report Filing (8-k)
11/06/201916:30PRNUSProtagonist Therapeutics Reports Third Quarter 2019..
11/06/201916:01PRNUSProtagonist Therapeutics Announces First Patient Dosed in a..
10/31/201917:26EDGARSecurities Registration Statement (simplified Form) (s-3)
10/31/201916:52EDGARCurrent Report Filing (8-k)
10/31/201907:00PRNUSProtagonist Therapeutics Secures Debt Facility for up to $50..
10/30/201916:49PRNUSProtagonist Therapeutics Initiates Phase 2 Study of Novel..
10/01/201907:00PRNUSProtagonist Therapeutics Announces Acceptance of Abstracts..
9/25/201907:00PRNUSProtagonist Therapeutics to Present at the Cantor Global..
9/04/201916:30PRNUSProtagonist Therapeutics Reports Granting of Inducement..
9/03/201916:30PRNUSProtagonist Therapeutics to Present at the H.C. Wainwright &..
8/07/201917:23EDGARQuarterly Report (10-q)
8/07/201909:29EDGARCurrent Report Filing (8-k)
8/07/201907:00PRNUSProtagonist Therapeutics Reports Second Quarter 2019..
8/01/201916:30PRNUSOral Alpha-4-Beta-7 Integrin Antagonist PN-943 Demonstrates..
7/16/201916:05PRNUSProtagonist Therapeutics Reports Granting of Inducement..
7/01/201916:51EDGARStatement of Ownership (sc 13g)
6/18/201916:30PRNUSProtagonist Therapeutics Reports Granting of Inducement..
6/17/201916:07EDGARStatement of Ownership (sc 13g)
6/17/201907:00PRNUSProtagonist Therapeutics to Present at the BMO 2019..
6/13/201916:02EDGARCurrent Report Filing (8-k)
6/11/201918:34EDGARStatement of Changes in Beneficial Ownership (4)
6/11/201918:32EDGARStatement of Changes in Beneficial Ownership (4)
6/11/201918:30EDGARStatement of Changes in Beneficial Ownership (4)
6/11/201918:28EDGARStatement of Changes in Beneficial Ownership (4)
6/11/201918:27EDGARStatement of Changes in Beneficial Ownership (4)
6/11/201918:21EDGARStatement of Changes in Beneficial Ownership (4)
6/04/201907:00PRNUSProtagonist Therapeutics Reports Granting of Inducement..
6/03/201919:40EDGARStatement of Changes in Beneficial Ownership (4)
6/03/201919:36EDGARInitial Statement of Beneficial Ownership (3)
5/29/201916:51EDGARCurrent Report Filing (8-k)
5/29/201916:30PRNUSProtagonist Therapeutics Appoints Don Kalkofen as Chief..
5/16/201918:45EDGARStatement of Changes in Beneficial Ownership (4)
5/14/201907:00PRNUSOral Alpha-4-Beta-7 Integrin Antagonist PN-943 Demonstrates..
5/13/201917:19EDGARCurrent Report Filing (8-k)
See more news about this stock »
Your Recent History
NASDAQ
PTGX
Protagonis..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200126 09:51:03